Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on October 15, 2026
Domestic drug production could reduce, not end, shortage risk
A manufacturing lawyer says US production and local supply chains may help, while shortages have multiple causes.
Today in brief
Marc Wagner said expanding US pharmaceutical production could lower drug-shortage risk, but not eliminate it.1
Manufacturing
Most generic drug products are made outside the United States, Wagner said, leaving overseas facilities to help meet supply needs.1 He said restoring domestic production of active pharmaceutical ingredients and localizing supply chains could reduce manufacturing disruptions.1 Domestic facilities are easier for the FDA to inspect, with less travel and resource burden, Wagner said.1 Shortages have multiple causes, and no single measure can solve them, he said.1